As of July 2026, 450 paid clinical trials are recruiting in Kansas City, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Kansas City offers studies at sites including University of Kansas Medical Center for conditions such as Acute Myeloid Leukemia, Cystic Fibrosis, Heart Failure, Interstitial Lung Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Kansas City, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Medical Center | Cystic Fibrosis, Heart Failure, Obesity | 176 |
| University of Kansas Cancer Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Metastatic Malignant Solid Neoplasm | 85 |
| The University of Kansas Medical Center | Adenoma, Adjustment Disorder, Ankle Fracture (bimalleolar Equivalent, Bimalleolar, or Trimalleolar) | 22 |
| Kansas University Medical Center | DM1, Myotonic Dystrophy 1, Acute GVHD | 12 |
| University of Kansas | Idiopathic Pulmonary Fibrosis, Lung Diseases, Asthma | 9 |
| University of Kansas Hospital | Prostate Cancer, Atrial Fibrillation, Cardiovascular Disease and Lipoprotein(a) | 9 |
| University of Kansas Medical Center Research Institute | Gastroesophageal Junction Adenocarcinoma, Acute Myeloid Leukemia, COPD | 6 |
| The University of Kansas Cancer Center | AML, AML With Mutated NPM1, Abdominal Neoplasm | 5 |
| The University of Kansas Cancer Center, Westwood Campus | NSCLC Stage IV, Locally Advanced Lung Carcinoma, Lung Cancer | 5 |
| University of Kansas Medical Center Research Institute, Inc. | Acute Myeloid Leukemia, Atrial Fibrillation, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | 5 |
| Clinical Trial Site | ATTR Amyloidosis, High Cardiovascular Risk, High Risk Cardiovascular Disease | 4 |
| The University of Kansas Hospital | Acute Myeloid Leukemia, Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer | 4 |
| University of Kansas Medical Center (KUMC) | DMD, Duchenne Muscular Dystrophy, Exon 44 | 4 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2 | 2 |
| Clinical Associates Midwest, LLC | Acute Treatment of Migraine, Pediatric Migraine | 2 |
| Clinical Study Site | Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy | 2 |
| Kansas City VA Medical Center | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 2 |
| Mobility and Falls Lab | Multiple Sclerosis, Parkinson's Disease (PD), Spasticity | 2 |
| The University of Kansas | Aortic Stenosis, Cystitis Recurrent, Recurrent UTIs | 2 |
| The University of Kansas Cancer Center - Westwood | Advanced NSCLC, Breast Cancer, Lung Cancer | 2 |
| The University of Kansas Health System | Acute Ischemic Stroke, Burns, Skin Graft Complications | 2 |
| The University of Kansas Medical Center Medical Office Building | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 2 |
| Univeristy of Kansas Medical Center | Alzheimer Disease, FSHD, Healthy Aging | 2 |
| University of Kansas Health System | Cesarean Delivery, General Anesthesia, Lower Urinary Tract Symptoms | 2 |
| University of Kansas Hospital Cambridge North Tower A | Acute Myeloid Leukemia, Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer | 2 |
Recruiting trials in Kansas City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 450 recruiting clinical trials in Kansas City, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Kansas City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Kansas City include Acute Myeloid Leukemia (10), Cystic Fibrosis (10), Heart Failure (10), Interstitial Lung Disease (7), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kansas City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Kansas City include University of Kansas Medical Center, University of Kansas Cancer Center, The University of Kansas Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Kansas City are Cancer & tumors (124), Neurology & pain (50), Cardiovascular (37). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.